Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug ...
A new investigational cancer vaccine developed by Merck & Co. and Moderna is customized based on the genome of each patient's ...
A WuXi AppTec director examines strategies for improving oral PROTAC exposure, from food-effect studies and linker design to ...
AbbVie's MAVYRET became the first of those antivirals cleared for acute infection in June 2025, with a 96% cure rate in trial ...
Medable’s Pamela Tenaerts says “the CRA still needs to be there,” as she and Tufts’ Ken Getz explain how agents change ...
The FDA has approved ViiV Healthcare’s Tivicay PD (dolutegravir) for treating HIV-1 in pediatric patients weighing at least 2 ...
FDA has logged more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide as regulators, ...
The FDA has finalized new guidelines for meetings between the FDA and sponsors or applicants relating to the development and review of drugs or biological products under the Prescription Drug User Fee ...
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
The GLP-1 wave keeps widening Semaglutide hits the GLP-1 receptor alone, tirzepatide adds a second in GIP, and next-generation candidates layer on a third in glucagon or drop incretins altogether for ...
A new international collaboration backed by a pan-European EUREKA grant aims to develop targeted small-molecule therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results